Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Matrix Biology : Journal of the International Society for Matrix Biology|November 29, 2007
TSG-6 binds via its CUB_C domain to the cell-binding domain of fibronectin and increases fibronectin matrix assemblySvetlana A Kuznetsova, David J Mahoney, Gema Martin-Manso, et al.
Cardiovascular Research|July 9, 2010
Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxationEileen M Bauer, Yan Qin, Thomas W Miller, et al.
Blood|November 4, 2006
Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxationJeff S Isenberg, Fuminori Hyodo, Ken-Ichiro Matsumoto, et al.
Nature Communications|November 3, 2019
An anionic, endosome-escaping polymer to potentiate intracellular delivery of cationic peptides, biomacromolecules, and nanoparticlesBrian C Evans, R Brock Fletcher, Kameron V Kilchrist, et al.
Plos One|April 3, 2020
A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncologyTeresa L Burgess, Joshua D Amason, Jeffrey S Rubin, et al.
Oncotarget|February 4, 2016
A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancerSukhbir Kaur, Abdel G Elkahloun, Satya P Singh, et al.
Transplantation Direct|March 25, 2026
Donation After Circulatory Death Islets are Comparable to Standard-of-Care Donation After Brain Death Islets: Analysis of 801 Consecutive Human Islet IsolationsMeirigeng Qi, Keiko Omori, Christopher Orr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2014
CD47 signaling regulates the immunosuppressive activity of VEGF in T cellsSukhbir Kaur, Tiffany Chang, Satya P Singh, et al.
Autophagy|August 10, 2012
CD47 deficiency confers cell and tissue radioprotection by activation of autophagyDavid R Soto-Pantoja, Thomas W Miller, Michael L Pendrak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cellsSara E Bass, Pawel Sienkiewicz, Christopher J Macdonald, et al.
Pageof 21